Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06792344 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis

StatusSuspended
PhasePhase 1
Started2025-12-14
View on ClinicalTrials.gov ↗

Amendment history

2026-09-03
Recruiting→Suspended Study Status, Contacts/Locations v2
Recruitment suspended: temporarily suspended due to no new subjects at present
Completion pushed: 2027-12-30 → 2028-12-31
Trial statusRecruiting→Suspended
Primary completion date2027-12-30→2027-12-14
Start date2024-12-15→2025-12-14
Study sitesdetails revised at 2 of 2 sites
2025-12-16
Study Status, Sponsor/Collaborators, Oversight v1
Collaborators+45 characters
Guangzhou Women and Children's Medical Center
2025-01-20
Original filing
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-CD19 CAR-T cells in the treatment of childhood-onset systemic sclerosis
Trial Details
NCT Number NCT06792344
Lead Sponsor The Children's Hospital of Zhejiang University School of Medicine
Collaborators: Guangzhou Women and Children's Medical Center
Conditions Systemic Sclerosis (SSc)
Enrollment 12 participants
Start Date 2025-12-14
Primary Completion 2027-12-14 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-08